0001192482-18-000260.txt : 20180604 0001192482-18-000260.hdr.sgml : 20180604 20180604180053 ACCESSION NUMBER: 0001192482-18-000260 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180531 FILED AS OF DATE: 20180604 DATE AS OF CHANGE: 20180604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ciaffoni Joseph CENTRAL INDEX KEY: 0001443841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37372 FILM NUMBER: 18879407 MAIL ADDRESS: STREET 1: C/O ENDO HEALTH SOLUTIONS INC. STREET 2: 1400 ATWATER DRIVE CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC CENTRAL INDEX KEY: 0001267565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 DEDHAM STREET, SUITE 800 CITY: CANTON STATE: MA ZIP: 02021 BUSINESS PHONE: 781-713-3699 MAIL ADDRESS: STREET 1: 780 DEDHAM STREET, SUITE 800 CITY: CANTON STATE: MA ZIP: 02021 FORMER COMPANY: FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC DATE OF NAME CHANGE: 20031020 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-05-31 0001267565 COLLEGIUM PHARMACEUTICAL, INC COLL 0001443841 Ciaffoni Joseph C/O COLLEGIUM PHARMACEUTICAL, INC. 780 DEDHAM STREET, SUITE 800 CANTON MA 02021 0 1 0 0 Chief Operating Officer Common Stock 2018-05-31 4 M 0 64821 8.22 A 174089 D Common Stock 2018-05-31 4 S 0 59204 22.54 D 114885 D Common Stock 2018-05-31 4 S 0 5617 23.35 D 109268 D Common Stock 2018-05-31 4 F 0 6205 22.62 D 103063 D Common Stock 2018-06-01 4 S 0 14862 22.48 D 88201 D Stock option (right to purchase) 8.22 2018-05-31 4 M 0 64821 0 D 2027-05-31 Common Stock 64821 194462 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2017. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.10 to $23.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (5). The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.10 to $23.45, inclusive. Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.14 to $22.91, inclusive. 64,821 shares subject to the option vested and became exercisable on May 31, 2018. The remaining 194,462 shares subject to the option vest in equal quarterly installments (rounded up to the nearest whole share of common stock) over a three year period, subject to the reporting person's continued service with the issuer. /s/ Paul Brannelly as Attorney-In-Fact For Joseph Ciaffoni 2018-06-04